Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-21ANL3Form 3 Filing - Initial Statement of Beneficial OwnershipMEDIUM
This filing is an initial statement of beneficial ownership for Adlai Nortye Ltd. (ANL). The reporting owner, LU YANG, who is the CEO, Director, and a ten percent owner, reported the ownership of 100,000 American Depositary Shares directly. Additionally, 1,6990,000 Class B ordinary shares are held indirectly through a ...
Small CapBiotechnology
2026-05-21CRBP3Power of Attorney for Brent Pfeiffenberger
This filing contains a Power of Attorney document filed by Brent Pfeiffenberger, a director at Corbus Pharmaceuticals Holdings, Inc. The document, dated May 15, 2026, grants power of attorney to Yuval Cohen, Ph.D., Sean Moran, and Meghan Houghton. They are authorized to execute and file various securities disclosure do...
Micro CapBiotechnology